The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Regulatory News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 338.00
Bid: 335.00
Ask: 338.00
Change: 25.00 (7.99%)
Spread: 3.00 (0.896%)
Open: 324.00
High: 346.00
Low: 323.00
Prev. Close: 313.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Standard form for notification of major holdings

17 May 2023 09:30

RNS Number : 7197Z
Hutchmed (China) Limited
17 May 2023
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

HUTCHMED (China) Limited

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Canada Pension Plan Investment Board

City and country of registered office (if applicable)

Toronto, Canada

4. Full name of shareholder(s) (if different from 3.) v

Name

N/A

City and country of registered office (if applicable)

N/A

5. Date on which the threshold was crossed or reached vi:

15 May 2023

6. Date on which issuer notified (DD/MM/YYYY):

17/05/2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

Less than 3%

Position of previous notification (if

applicable)

3.17

0.00

3.17

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Ordinary Shares

KYG4672N1198

SUBTOTAL 8. A

Less than 3%

Less than 3%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional information xvi

 

Place of completion

London, UK

Date of completion

16 May 2023

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLGRGDURBBDGXR
Date   Source Headline
10th Jun 201912:02 pmRNSPrice Monitoring Extension
6th Jun 20197:00 amRNSDisclosure Update
31st May 20194:40 pmRNSSecond Price Monitoring Extn
31st May 20194:35 pmRNSPrice Monitoring Extension
29th May 201912:06 pmRNSResults of Extraordinary General Meeting
22nd May 201911:03 amRNSGrant of Share Options under Share Option Scheme
3rd May 20197:00 amRNSNotice of EGM & Shareholder Circular
24th Apr 20191:54 pmRNSResults of AGM
15th Apr 20197:30 amRNSDisclosure Update
15th Apr 20197:00 amRNSHK Listing Application - Proposed Global Offering
29th Mar 20197:00 amRNSStart of Phase IIb/III Surufatinib Trial in China
28th Mar 20197:30 amRNSSavolitinib Lung Cancer Presentations at AACR
25th Mar 20197:00 amRNSVesting of awards under Long Term Incentive Plan
21st Mar 20197:00 amRNSChi-Med 2018 Annual Report and Notice of AGM
11th Mar 201912:54 pmRNSPublication of Form 20-F
11th Mar 20197:00 amRNS2018 FY Results and Key Clinical Programs Update
12th Feb 20197:00 amRNSSavolitinib PRCC Data to be presented at ASCO GU
8th Feb 20197:00 amRNSChi-Med to Announce 2018 Final Results
7th Jan 20197:00 amRNSChi-Med Presents at JPM Healthcare Conference
31st Dec 20187:00 amRNSBlocklisting Six Monthly Return
31st Dec 20187:00 amRNSTotal Voting Rights
24th Dec 201812:41 pmRNSSecond Price Monitoring Extn
24th Dec 201812:36 pmRNSPrice Monitoring Extension
20th Dec 20187:13 amRNSChi-Med announce Savolitinib program update
20th Dec 20187:00 amRNSAmendment to Lilly Agreement on Fruquintinib
14th Dec 20187:21 amRNSTR-1: Form for notification of major holdings
30th Nov 20187:00 amRNSTotal Voting Rights
29th Nov 20188:00 amRNSChi-Med Enters into Multiple Collaborations
26th Nov 20187:00 amRNSFirst Commercial Launch of Fruquintinib Capsules
16th Nov 20187:00 amRNSPhase III FALUCA Trial Results for Fruquintinib
31st Oct 20187:00 amRNSTotal Voting Rights
22nd Oct 201810:05 amRNSGrant of Share Options under Share Option Scheme
18th Oct 20187:00 amRNSChi-Med Initiates a Ph I Trial of HMPL-523 for AML
5th Oct 20187:00 amRNSAppointment of HSBC Bank plc as Broker in London
5th Sep 20187:00 amRNSFruquintinib Approved for CRC in China
31st Aug 20187:00 amRNSTotal Voting Rights
7th Aug 201810:00 amRNSGrant of Share Options under Share Option Scheme
27th Jul 20187:00 amRNS2018 Interim Results and Clinical Programs Update
23rd Jul 20187:00 amRNSStart of Sulfatinib US Phase Ib/II PoC trial
29th Jun 20187:02 amRNSTotal Voting Rights
29th Jun 20187:01 amRNSBlocklisting Six Monthly Return
29th Jun 20187:00 amRNSChi-Med to Announce Half-Year Financial Results
7th Jun 201810:00 amRNSGrant of Share Options under Share Option Scheme
4th Jun 20189:41 amRNSFurther Fruquintinib FRESCO Trial Data - ASCO 2018
31st May 20187:00 amRNSTotal Voting Rights
30th Apr 20187:00 amRNSTotal Voting Rights
27th Apr 20181:52 pmRNSResults of Annual General Meeting
23rd Apr 20181:10 pmRNSGrant of Share Options under Share Option Scheme
23rd Apr 20181:05 pmRNSBlock Admission
29th Mar 20187:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.